Surface-bound MPO is subsequently transcytosed through endothelial cells, and deposited in the sub-endothelial space, where it catalyses oxidative reactions that impair NO bioactivity and promote endothelial dysfunction and vasoconstriction (Figure 2A) [49,50,92,95]. Here, MPO is linked to endothelial dysfunction.